Medical device recalls Moderate risk

Luminex Corporation recalls VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERI…

Recall date
April 16, 2025
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1903-2025
FDA classification
Class II
Brand / firm
Luminex Corporation
Sold / distributed
US Nationwide distribution in the states of AL, CA, MN, TX, AZ, NJ, WA, SC, VA, GA, VT, CT, MD.

Why it was recalled

It was determined that the consumable issue may result in No Call - INT CTL 1 and/or False Negative results on a small portion of the lot of test cartridges.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGENE System; invitro diagnostic test

Get recall alerts

Free email alert whenever Luminex Corporation has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Luminex Corporation